Speakers:

Avi Reichental, President and CEO, 3D Systems

Peter Weijmarshausen, CEO and Co-Founder, Shapeways
Moderator:

Jamal Simmons, Principal, The Raben Group; Political Analyst. Will 3D printing launch the era of widespread human tissue engineering? Is it going to relocalize manufacturing, upsetting global supply chains and other facts of economic life? What's real about 3D printing, and what's hype? In theory, this technology for layering materials into complex objects can create customized products on a mass scale, bypassing traditional industrial and even scientific techniques. It is already used, largely for prototyping, in the automotive, aerospace, medical and other fields, but considered still in its infancy. Our panel will illuminate how the technology works and gauge its eventual impact. Which industries will see 3D printing as a boon, and which may be on the losing end? How can entrepreneurs make use of it, and could it help small and medium-sized businesses level the playing field with their larger competitors? What will the technology do to business costs and employment? How are regulators looking at these developments?